Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STK17B | O94768 | 1/20 | 0.35 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.35 |
| ▸ | KMT5A | Q9NQR1 | 1/20 | 0.34 |
| ▸ | SUV39H2 | Q9H5I1 | 6/20 | 0.33 |
| ▸ | PGK1 | P00558 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.32 |
| ▸ | TNF | P01375 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6822467 | 0.88 | KMT5A (0.34) | KMT5ABRD4TNFEHMT2 | |
| SCHEMBL6817664 | 0.88 | KMT5A (0.34) | STK17BSTK17AKMT5ABRD4LRRK2 | |
| SCHEMBL6817843 | 0.83 | SCN9A (0.37) | STK17BSTK17AKMT5ALRRK2TNF | |
| SCHEMBL6817533 | 0.83 | HSP90AA1 (0.37) | KMT5A | |
| SCHEMBL6817777 | 0.81 | BRD4 (0.37) | BRD4 | |
| SCHEMBL6818015 | 0.79 | ACP1 (0.36) | KMT5ABRD4 | |
| SCHEMBL6084266 | 0.77 | IDO1 (0.35) | SMN1; SMN2 | |
| SCHEMBL6813647 | 0.75 | ACP1 (0.43) | SMN1; SMN2 | |
| SCHEMBL6817674 | 0.74 | CRHR1 (0.36) | ACHE | |
| SCHEMBL6814612 | 0.74 | BCHE (0.30) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004031189-A1 | PYRIDINO AND PYRIMIDINO PYRAZINONES FOR TREATMENT OF ANXIETY AND DEPRESSION | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2004-04-15 | — | — | WO | disclosed |